Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma

Asthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce clinical airway inflammation, bronchial hyperresponsiveness, and reversible obstruction of airways. Studies have demonstrated the presence of T-helper 2 lymphocytes in the lu...

Full description

Saved in:
Bibliographic Details
Main Authors: Francieli Vuolo, Fabricia Petronilho, Beatriz Sonai, Cristiane Ritter, Jaime E. C. Hallak, Antonio Waldo Zuardi, José A. Crippa, Felipe Dal-Pizzol
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/538670
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396695019814912
author Francieli Vuolo
Fabricia Petronilho
Beatriz Sonai
Cristiane Ritter
Jaime E. C. Hallak
Antonio Waldo Zuardi
José A. Crippa
Felipe Dal-Pizzol
author_facet Francieli Vuolo
Fabricia Petronilho
Beatriz Sonai
Cristiane Ritter
Jaime E. C. Hallak
Antonio Waldo Zuardi
José A. Crippa
Felipe Dal-Pizzol
author_sort Francieli Vuolo
collection DOAJ
description Asthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce clinical airway inflammation, bronchial hyperresponsiveness, and reversible obstruction of airways. Studies have demonstrated the presence of T-helper 2 lymphocytes in the lung of patients with asthma. These cells are involved in cytokine production that regulates immunoglobulin synthesis. Recognizing that T cell interaction with antigens/allergens is key to the development of inflammatory diseases, the aim of this study is to evaluate the anti-inflammatory potential of cannabidiol (CBD) in this setting. Asthma was induced in 8-week-old Wistar rats by ovalbumin (OVA). In the last 2 days of OVA challenge animals received CBD (5 mg/kg, i.p.) and were killed 24 hours after. The levels of IL-4, IL-5, IL-13, IL-6, IL-10, and TNF-α were determinate in the serum. CBD treatment was able to decrease the serum levels of all analyzed cytokines except for IL-10 levels. CBD seems to be a potential new drug to modulate inflammatory response in asthma.
format Article
id doaj-art-b02caa32c9144f529fb7666b66445e33
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-b02caa32c9144f529fb7666b66445e332025-08-20T03:39:15ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/538670538670Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of AsthmaFrancieli Vuolo0Fabricia Petronilho1Beatriz Sonai2Cristiane Ritter3Jaime E. C. Hallak4Antonio Waldo Zuardi5José A. Crippa6Felipe Dal-Pizzol7Laboratório de Fisiopatologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806000 Criciúma, SC, BrazilPrograma de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, 88704900 Tubarão, SC, BrazilLaboratório de Fisiopatologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806000 Criciúma, SC, BrazilLaboratório de Fisiopatologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806000 Criciúma, SC, BrazilDepartamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049900 Ribeirão Preto, SP, BrazilDepartamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049900 Ribeirão Preto, SP, BrazilDepartamento de Neurociências e Ciências do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14049900 Ribeirão Preto, SP, BrazilLaboratório de Fisiopatologia Experimental, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806000 Criciúma, SC, BrazilAsthma represents a public health problem and traditionally is classified as an atopic disease, where the allergen can induce clinical airway inflammation, bronchial hyperresponsiveness, and reversible obstruction of airways. Studies have demonstrated the presence of T-helper 2 lymphocytes in the lung of patients with asthma. These cells are involved in cytokine production that regulates immunoglobulin synthesis. Recognizing that T cell interaction with antigens/allergens is key to the development of inflammatory diseases, the aim of this study is to evaluate the anti-inflammatory potential of cannabidiol (CBD) in this setting. Asthma was induced in 8-week-old Wistar rats by ovalbumin (OVA). In the last 2 days of OVA challenge animals received CBD (5 mg/kg, i.p.) and were killed 24 hours after. The levels of IL-4, IL-5, IL-13, IL-6, IL-10, and TNF-α were determinate in the serum. CBD treatment was able to decrease the serum levels of all analyzed cytokines except for IL-10 levels. CBD seems to be a potential new drug to modulate inflammatory response in asthma.http://dx.doi.org/10.1155/2015/538670
spellingShingle Francieli Vuolo
Fabricia Petronilho
Beatriz Sonai
Cristiane Ritter
Jaime E. C. Hallak
Antonio Waldo Zuardi
José A. Crippa
Felipe Dal-Pizzol
Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
Mediators of Inflammation
title Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
title_full Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
title_fullStr Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
title_full_unstemmed Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
title_short Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
title_sort evaluation of serum cytokines levels and the role of cannabidiol treatment in animal model of asthma
url http://dx.doi.org/10.1155/2015/538670
work_keys_str_mv AT francielivuolo evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT fabriciapetronilho evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT beatrizsonai evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT cristianeritter evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT jaimeechallak evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT antoniowaldozuardi evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT joseacrippa evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma
AT felipedalpizzol evaluationofserumcytokineslevelsandtheroleofcannabidioltreatmentinanimalmodelofasthma